These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 30563969

  • 1. The FCGR2C allele that modulated the risk of HIV-1 infection in the Thai RV144 vaccine trial is implicated in HIV-1 disease progression.
    Lassaunière R, Paximadis M, Ebrahim O, Chaisson RE, Martinson NA, Tiemessen CT.
    Genes Immun; 2019 Nov; 20(8):651-659. PubMed ID: 30563969
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Variability at the FCGR locus: characterization in Black South Africans and evidence for ethnic variation in and out of Africa.
    Lassaunière R, Tiemessen CT.
    Genes Immun; 2016 Mar; 17(2):93-104. PubMed ID: 26673965
    [Abstract] [Full Text] [Related]

  • 4. FCGR2C Polymorphisms Associated with HIV-1 Vaccine Protection Are Linked to Altered Gene Expression of Fc-γ Receptors in Human B Cells.
    Peng X, Li SS, Gilbert PB, Geraghty DE, Katze MG.
    PLoS One; 2016 Mar; 11(3):e0152425. PubMed ID: 27015273
    [Abstract] [Full Text] [Related]

  • 5. Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.
    Li SS, Gilbert PB, Carpp LN, Pyo CW, Janes H, Fong Y, Shen X, Neidich SD, Goodman D, deCamp A, Cohen KW, Ferrari G, Hammer SM, Sobieszczyk ME, Mulligan MJ, Buchbinder SP, Keefer MC, DeJesus E, Novak RM, Frank I, McElrath MJ, Tomaras GD, Geraghty DE, Peng X.
    J Virol; 2019 Nov 01; 93(21):. PubMed ID: 31434737
    [Abstract] [Full Text] [Related]

  • 6. Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
    Bekker LG, Moodie Z, Grunenberg N, Laher F, Tomaras GD, Cohen KW, Allen M, Malahleha M, Mngadi K, Daniels B, Innes C, Bentley C, Frahm N, Morris DE, Morris L, Mkhize NN, Montefiori DC, Sarzotti-Kelsoe M, Grant S, Yu C, Mehra VL, Pensiero MN, Phogat S, DiazGranados CA, Barnett SW, Kanesa-Thasan N, Koutsoukos M, Michael NL, Robb ML, Kublin JG, Gilbert PB, Corey L, Gray GE, McElrath MJ, HVTN 100 Protocol Team.
    Lancet HIV; 2018 Jul 01; 5(7):e366-e378. PubMed ID: 29898870
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. FCGR3A gene duplication, FcγRIIb-232TT and FcγRIIIb-HNA1a associate with an increased risk of vertical acquisition of HIV-1.
    Ebonwu J, Lassaunière R, Paximadis M, Strehlau R, Gray GE, Kuhn L, Tiemessen CT.
    PLoS One; 2022 Jul 01; 17(9):e0273933. PubMed ID: 36084039
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection.
    Kim JH, Excler JL, Michael NL.
    Annu Rev Med; 2015 Jul 01; 66():423-37. PubMed ID: 25341006
    [Abstract] [Full Text] [Related]

  • 12. HIV Vaccine Efficacy Trials: RV144 and Beyond.
    Heger E, Schuetz A, Vasan S.
    Adv Exp Med Biol; 2018 Jul 01; 1075():3-30. PubMed ID: 30030787
    [Abstract] [Full Text] [Related]

  • 13. Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap.
    Gray GE, Mayer KH, Elizaga ML, Bekker LG, Allen M, Morris L, Montefiori D, De Rosa SC, Sato A, Gu N, Tomaras GD, Tucker T, Barnett SW, Mkhize NN, Shen X, Downing K, Williamson C, Pensiero M, Corey L, Williamson AL.
    Clin Vaccine Immunol; 2016 Jun 01; 23(6):496-506. PubMed ID: 27098021
    [Abstract] [Full Text] [Related]

  • 14. V1V2-specific complement activating serum IgG as a correlate of reduced HIV-1 infection risk in RV144.
    Perez LG, Martinez DR, deCamp AC, Pinter A, Berman PW, Francis D, Sinangil F, Lee C, Greene K, Gao H, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, Tartaglia J, O'Connell RJ, Robb ML, Michael NL, Kim JH, Gilbert P, Montefiori DC.
    PLoS One; 2017 Jun 01; 12(7):e0180720. PubMed ID: 28678869
    [Abstract] [Full Text] [Related]

  • 15. Extensive Ethnic Variation and Linkage Disequilibrium at the FCGR2/3 Locus: Different Genetic Associations Revealed in Kawasaki Disease.
    Nagelkerke SQ, Tacke CE, Breunis WB, Tanck MWT, Geissler J, Png E, Hoang LT, van der Heijden J, Naim ANM, Yeung RSM, Levin ML, Wright VJ, Burgner DP, Ponsonby AL, Ellis JA, Cimaz R, Shimizu C, Burns JC, Fijnvandraat K, van der Schoot CE, van den Berg TK, de Boer M, Davila S, Hibberd ML, Kuijpers TW, International Kawasaki Disease Genetics Consortium.
    Front Immunol; 2019 Jun 01; 10():185. PubMed ID: 30949161
    [Abstract] [Full Text] [Related]

  • 16. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B, Nchabeleng M, Ensoli F, Tripiciano A, Bellino S, Picconi O, Sgadari C, Longo O, Tavoschi L, Joffe D, Cafaro A, Francavilla V, Moretti S, Pavone Cossut MR, Collacchi B, Arancio A, Paniccia G, Casabianca A, Magnani M, Buttò S, Levendal E, Ndimande JV, Asia B, Pillay Y, Garaci E, Monini P, SMU-MeCRU study group.
    Retrovirology; 2016 Jun 09; 13(1):34. PubMed ID: 27277839
    [Abstract] [Full Text] [Related]

  • 17. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
    Cheeseman HM, Olejniczak NJ, Rogers PM, Evans AB, King DFL, Ziprin P, Liao HX, Haynes BF, Shattock RJ.
    J Virol; 2017 Jan 01; 91(1):. PubMed ID: 27795431
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The potential impact of a moderately effective HIV vaccine with rapidly waning protection in South Africa and Thailand.
    Andersson KM, Stover J.
    Vaccine; 2011 Aug 18; 29(36):6092-9. PubMed ID: 21703322
    [Abstract] [Full Text] [Related]

  • 20. Genome-Wide Analyses Reveal Gene Influence on HIV Disease Progression and HIV-1C Acquisition in Southern Africa.
    Xie W, Agniel D, Shevchenko A, Malov SV, Svitin A, Cherkasov N, Baum MK, Campa A, Gaseitsiwe S, Bussmann H, Makhema J, Marlink R, Novitsky V, Lee TH, Cai T, O'Brien SJ, Essex M.
    AIDS Res Hum Retroviruses; 2017 Jun 18; 33(6):597-609. PubMed ID: 28132517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.